Drugs / Mixed bacterial vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00623831 | May 2007 → May 2012 | breast cancer, esophageal cancer, gastrointestinal stromal tumor, head and neck cancer +5 | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mixed bacterial vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00623831 ↗ |
| Known as | Coley's toxins | “Mixed bacterial vaccine (MBV, Coley's toxins) is a historical, vaguely defined preparation of heat-inactivated Streptococcus pyogenes and Serratia marcescens used as...” PMID 22847809 ↗ Jul 2012 |
| Modality | Vaccine | “Mixed bacterial vaccine (MBV, Coley's toxins) is a historical, vaguely defined preparation of heat-inactivated Streptococcus pyogenes and Serratia marcescens used as...” PMID 22847809 ↗ Jul 2012 |
| Route | Subcutaneous | “by subcutaneous injection” NCT00623831 ↗ |